Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2007
10/11/2007US20070238659 Variants of vascular endothelial cell growth factors having antagonistic properties, nucleic acids encoding the same and host cells comprising those nucleic acids
10/11/2007US20070238658 IL-17A and IL-17F Antagonists and Methods of Using the Same
10/11/2007US20070238657 relates to nucleic acid sequences encoding a member of the fibroblast growth factor (FGF) family, and to polypeptides encoded by the nucleic acid sequence
10/11/2007US20070238650 Polymer-Conjugated Glycosylated Neublastin
10/11/2007US20070238646 Protein for use as tool in controlling plant pest; pesticides; biological pest control; moths and beetles
10/11/2007US20070238644 Human Chemokines CKBeta-4 and CKBeta-10/MCP-4
10/11/2007US20070238642 Production of Vascular Endothelial Cell Growth Factor and DNA Encoding Same
10/11/2007US20070238641 Pharmaceutical Combined Preparation Containing a Therapeutic Protein
10/11/2007US20070238639 Telomerase expression repressor proteins and methods of using the same
10/11/2007US20070238638 Bak promoter expression system
10/11/2007US20070238197 Fluorescent ligands for GPCR arrays
10/11/2007US20070238196 Methods of using an equine fc epsilon receptor alpha chain protein
10/11/2007US20070238195 Conformational and topological protein regulation
10/11/2007US20070238194 Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver and uses thereof
10/11/2007US20070238182 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
10/11/2007US20070238168 Double mutant alpha-7 nicotinic acetylcholine receptor
10/11/2007US20070238155 Construction of highly efficient cellulase compositions for enzymatic hydrolysis of cellulose
10/11/2007US20070238152 Genetically programmed expression of proteins containing the unnatural amino acid phenylselenocysteine
10/11/2007US20070238151 Novel compounds
10/11/2007US20070238150 Pro4356 polypeptides
10/11/2007US20070238143 Metal ion mediated fluorescence superquenching assays, kits and reagents
10/11/2007US20070238135 Novel g-protein coupled receptor and dna sequences thereof
10/11/2007US20070238134 Cell cycle proteins associated with rad9, compositions and methods of use
10/11/2007US20070238130 Novel Metalloproteinases
10/11/2007US20070238123 Method for determining cell cycle position
10/11/2007US20070238110 using molecular markers for identifying potential bovine carriers of the dwarfism mutation and for identifying the genetic locus and mutations thereof responsible for dwarfism and genetic markers test for assaying for the same
10/11/2007US20070238099 Antigen Receptor Variable Region Typing
10/11/2007US20070238086 Identification of oligonucleotides for the capture, detection and quantitation of West Nile virus
10/11/2007US20070237799 Osteogenic Composite Matrix, Method for the Production Thereof and Implant and Scaffold for Tissue Engineering Provided with a Coating Formed by Said Osteogenic Composite matrix
10/11/2007US20070237794 Compounds and Methods for Diagnosis and Treatment of Leishmaniasis
10/11/2007US20070237793 Attenuated or mutated pasteurella for use as tool in developing bactericidal agents; immunotherapy; immunogens for vaccines
10/11/2007US20070237790 Identification of gene sequences and proteins involved in vaccinia virus dominant T cell epitopes
10/11/2007US20070237785 Multiple antigen glycopeptide carbohydrate, vaccine comprising the same and use thereof
10/11/2007US20070237784 IdeS, an IgG-degrading enzyme of Streptococcus pyogenes
10/11/2007US20070237783 HIV peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIV
10/11/2007US20070237773 Human sema4a protein antibodies and uses thereof
10/11/2007US20070237771 Multicomponent conjugates which bind to target molecules and stimulate T cell lysis
10/11/2007US20070237768 Fibroblast growth factor 21 compounds fused to proteins that have the effect of extending the in vivo half-life of the polypeptides; these fusion proteins can be used to treat non-insulin dependent diabetes mellitus, obesity and metabolic syndrome
10/11/2007US20070237764 Binding polypeptides with restricted diversity sequences
10/11/2007US20070237754 Transient immortalization
10/11/2007US20070237753 Method for selectively transducing pathologic mammalian cells using a tumor suppressor gene
10/11/2007US20070237745 SISP-1 (Stress induced Secreted Protein 1); induces apoptosis by interaction with p53; treating abnormal apoptosis such as tumor
10/11/2007CA2647775A1 Synthetic peptides useful in the treatment of the skin and use thereof in cosmetic or dermopharmaceutical compositions
10/11/2007CA2647718A1 Maize genes for controlling plant growth and organ size and their use in improving crop plants
10/11/2007CA2647465A1 Pharmaceutical composition containing the nmb0606 protein
10/11/2007CA2646892A1 Peptide compound with biological activity, its preparation and its application
10/11/2007CA2645904A1 Pseudomonas aeruginosa outer membrane protein pa0427
10/11/2007CA2645245A1 Compositions and methods for treating atherosclerosis
10/11/2007CA2638821A1 Gene disruptons, compositions and methods relating thereto
10/10/2007EP1842919A1 DNA sequences having anti-repressor activity
10/10/2007EP1842918A1 Receptor nucleic acids and polypeptides
10/10/2007EP1842917A1 Sequences of an Ih ion channel and their application
10/10/2007EP1842907A1 A group of novel enantioselective microbial nitrile hydratases with broad substrate specificity
10/10/2007EP1842859A2 Monoclonal antibody specific for beta A4 peptide
10/10/2007EP1842857A1 Mutant interferon proteins and use thereof
10/10/2007EP1842856A2 Hypoxia inducing factors and uses thereof for inducing angiogenesis and improving muscular functions
10/10/2007EP1842553A1 Combination of an anti-EDb fibronectin domain antibody/IL2 fusion protein and a further small molecule
10/10/2007EP1842549A2 Optimized minigenes and peptides encoded thereby
10/10/2007EP1842548A1 Anti-hiv drug, polypeptide constituting the same, gene encoding the polypeptide and method of producing the anti-hiv drug
10/10/2007EP1842066A2 Biologically active silver-coated proteins
10/10/2007EP1841887A2 Cx3cr1 as a marker which correlates with both disease and disease activity in multiple sclerosis patients
10/10/2007EP1841872A2 Hemoglobin overexpression in fungal fermentations
10/10/2007EP1841870A1 Nitrogen-regulated sugar sensing gene and protein and modulation thereof
10/10/2007EP1841792A2 Method for producing albumin conjugates containing gyrase inhibitors
10/10/2007EP1841791A2 Means and methods for breaking noncovalent binding interactions between molecules
10/10/2007EP1841790A2 Ephb receptor-binding peptides
10/10/2007EP1841789A2 Hiv resistance genes
10/10/2007EP1841788A1 Novel snake toxin
10/10/2007EP1841787A2 Conjugates of biologically active proteins having a modified in vivo half-life
10/10/2007EP1841786A2 Method for screening antifungal agents
10/10/2007EP1841785A2 Compositions comprising pathogen-associated molecular patterns and antigens and their use to stimulate an immune response
10/10/2007EP1841784A1 Vacuole targeting peptide and nucleic acid
10/10/2007EP1841783A2 Second tc complex from xenorhabdus
10/10/2007EP1841781A1 Use of il-22 for the treatment of conditions of metabolic disorders
10/10/2007EP1841446A1 Peptides and compounds that bind to the il-5 receptor
10/10/2007EP1720979B1 Use of a serum-free cell culture medium for the production of il-18bp in mammalian cells
10/10/2007EP1572957A4 Identification of polynucleotides for predicting activity of compounds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in breast cells
10/10/2007EP1520036B1 New mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance
10/10/2007EP1401504B1 Uv-screening peptide-flavonoid conjugates
10/10/2007EP1385882B1 Peptides and related molecules that bind to tall-1
10/10/2007EP1320384B1 The synergetic effects of hgf and antibacterial treatment
10/10/2007EP1272215B1 Pharmaceutical preparations comprising modified peptides
10/10/2007EP1231927B1 Compositions comprising vernix and an uv protectant and their use
10/10/2007EP1200473B1 G-Protein coupled RECEPTOR
10/10/2007EP1177301B1 Chlamydia antigens and corresponding dna fragments and uses thereof
10/10/2007EP1173195B1 UTEROGLOBIN IN THE TREATMENT OF IgA MEDIATED AUTOIMMUNE DISORDERS
10/10/2007EP1155322B1 Compounds and methods for diagnosing trypanosoma cruzi infection
10/10/2007EP1133568B1 Regulatory sequences useful for gene expression in plant embryo tissue
10/10/2007EP1090924B1 Tumor antigen peptides originating in cyclophilin b
10/10/2007EP1049792B1 Methods for recovering polypeptides from plants and portions thereof
10/10/2007EP1012271B1 Methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
10/10/2007EP1012184B1 Derivatives of growth hormone and related proteins
10/10/2007EP0978565B1 Process for producing peptide with the use of accessory peptide
10/10/2007EP0975792B1 Isolation of tissue specific peptide ligands and their use for targeting pharmaceuticals to organs
10/10/2007EP0669973B9 Biological factors and neural stem cells
10/10/2007CN101052708A Serum-free cell culture medium for mammalian cells
10/10/2007CN101052651A Caspase-2 inhibitors and their biological applications
10/10/2007CN101052650A Novel peptide for treating obesity
10/10/2007CN101052649A Peptide for treating obesity
10/10/2007CN101052648A Novel peptide for treating obesity
1 ... 842 843 844 845 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 ... 2916